Progesterone, in various forms, has been the sole pharmacologic weapon against preterm labor supported by randomized controlled trials since the groundbreaking work of da Fonseca 1 and Meis 2 in the early 2000s.
Progesterone is indicated in preventing recurrent preterm labor and preterm delivery in the setting of a history preterm delivery due to cervical insufficiency or unexplained preterm delivery. This is what the evidence supports. However, many investigators are trying to expand the indications for the use of progesterone. These include using progesterone in twin pregnancies and in the setting of a short cervix. To date, no investigator has published data supporting the use of of progesterone in multiple gestations. However, there is good evidence to support the use of progesterone in women with a short cervix. It is hoped that the information provided in this review will be helpful to practitioners who care for at risk women. 
